We are live on ! Find out more
HOOK

HOOKIPA Pharma

Delisted

HOOK was delisted on the 7th of August, 2025.

53 hedge funds and large institutions have $109M invested in HOOKIPA Pharma in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 10

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

58% more capital invested

Capital invested by funds: $69M → $109M (+$40.2M)

8% more funds holding

Funds holding: 4953 (+4)

0.53% more ownership

Funds ownership: 3.34%3.87% (+0.53%)

100% less call options, than puts

Call options by funds: $6K | Put options by funds: $1.73M

Holders
53
Holders Change
+4
Holders Change %
+8.16%
% of All Funds
0.94%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
20
Reduced
10
Closed
6
Calls
$6K
Puts
$1.73M
Net Calls
-$1.73M
Net Calls Change
-$1.52M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$28.3M +$18.7M +173,400 +212%
RG
2
Redmile Group
California
$20.4M
AG
3
Artal Group
Luxembourg
$10.5M +$3.78M +35,000 +58%
HA
4
HHLR Advisors
Cayman Islands
$10.5M
Vanguard Group
5
Vanguard Group
Pennsylvania
$8.21M +$1.16M +10,764 +17%
BBA
6
Baker Bros. Advisors
New York
$7.77M
BlackRock
7
BlackRock
New York
$7.13M +$195K +1,806 +3%
DCM
8
DAFNA Capital Management
California
$2.77M +$2.46M +22,794 +1,033%
State Street
9
State Street
Massachusetts
$2.22M -$10.6K -98 -0.5%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$1.81M +$181K +1,671 +11%
Northern Trust
11
Northern Trust
Illinois
$1.66M +$78.5K +727 +5%
MIM
12
Monashee Investment Management
Massachusetts
$998K +$972K +9,000 New
N
13
Nuveen
North Carolina
$572K -$86K -796 -13%
Bank of America
14
Bank of America
North Carolina
$545K +$46K +426 +9%
SSA
15
Schonfeld Strategic Advisors
New York
$522K +$508K +4,701 New
Bank of New York Mellon
16
Bank of New York Mellon
New York
$452K +$77.1K +714 +21%
JP Morgan Chase
17
JP Morgan Chase
New York
$376K +$264K +2,448 +259%
Charles Schwab
18
Charles Schwab
California
$362K
EGM
19
Engineers Gate Manager
New York
$313K +$305K +2,823 New
California Public Employees Retirement System
20
California Public Employees Retirement System
California
$309K -$28.4K -263 -9%
Millennium Management
21
Millennium Management
New York
$286K +$169K +1,563 +154%
Wells Fargo
22
Wells Fargo
California
$271K +$2.7K +25 +1%
Morgan Stanley
23
Morgan Stanley
New York
$269K +$145K +1,346 +125%
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$260K +$143K +1,319 +128%
Tudor Investment Corp
25
Tudor Investment Corp
Connecticut
$222K +$216K +2,000 New

HOOK Hedge Fund Activity: Q4 2020 in Review

53 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q4 2020, worth a combined $109M — up 58% from $69M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new HOOK positions and 6 closed out — a net gain of 4 holders — while 20 added to existing stakes and 10 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $18.7M. The largest seller was Zacks Investment Management, exiting entirely with an estimated $682K sold.

  • 53 institutional investors held HOOKIPA Pharma (HOOK) as of Q4 2020, up from 49 in Q3 2020.
  • Funds reported $109M of HOOKIPA Pharma stock for Q4 2020, up 58% quarter-over-quarter.
  • 10 funds opened new HOOKIPA Pharma positions in Q4 2020 and 6 closed out, a net change of +4 holders.
  • The largest HOOKIPA Pharma buyer in Q4 2020 was Fidelity Investments, an estimated $18.7M added.
  • The largest HOOKIPA Pharma seller in Q4 2020 was Zacks Investment Management, an estimated $682K sold.

Based on aggregated 13F filings for Q4 2020.